Academic Article, April 2026
Strategic Directions in Overcoming Platinum-Resistant Ovarian Cancer: A Paradigm Shift Asst.Prof. Yuthasak SuphasynthDepartment of Obstetrics and Gynaecology,Faculty of Medicine, Prince of Songkla University For decades, the management of Platinum-Resistant Ovarian Cancer (PROC) has been constrained by a therapeutic plateau, where sequential non-platinum chemotherapy (weekly paclitaxel, PLD, gemcitabine, or topotecan) with…